Every pharmaceutical manufacturer knows the problem. You need to qualify a new excipient supplier. Your QA team runs the process: documentation review, risk assessment, audit scheduling. Weeks pass. Sometimes months. And if the supplier’s quality system turns out to be poorly documented or inconsistently implemented, you start again.

This is not a marginal issue. It is one of the most resource-intensive steps in pharmaceutical supply chain management, and it repeats every time you add or re-qualify a supplier.

DC Fine Chemicals has achieved GMP & EXCiPACT certification, an internationally recognised third-party standard for pharmaceutical excipient suppliers. For procurement and quality teams working under GMP constraints, this changes the qualification conversation significantly.

Why excipient supplier qualification is a persistent pain point

Good Manufacturing Practice (GMP) is the regulatory framework governing the safety, quality, and traceability of pharmaceutical products. Required by global authorities including the FDA and EMA, GMP applies not only to drug manufacturers but also to the materials they source.

Pharmaceutical companies are legally responsible for qualifying their excipient suppliers. In practice, this means that without recognised third-party certification, every new supplier relationship requires:

  1. A full documentation review of the supplier’s quality system
  2. A risk-based assessment of the supplier’s GMP alignment
  3. Access to detailed, up-to-date compliance documentation, including audit reports to support internal quality reviews and regulatory submissions

Depending on the risk profile of the excipient, an on-site audit may also be required. Without a recognised third-party certification in place, that audit falls entirely on the customer’s QA team or a commissioned auditor, adding time, cost, and resource pressure to an already demanding process. The higher the perceived risk of a supplier, the heavier that burden becomes.

What EXCiPACT certification means in practice

EXCiPACT is an independent, voluntary certification scheme developed specifically for pharmaceutical excipient manufacturers and distributors. It was created by industry bodies including IPEC Europe, IPEC Americas, EFCG, FECC, and PQG, and is built on three recognised standards:

  • IPEC-PQG GMP Guide: the pharmaceutical industry’s own GMP guideline for excipient suppliers
  • GDP (Good Distribution Practice): ensuring quality is maintained throughout the supply chain
  • ISO 9001 Quality Management System: a globally recognised framework for consistent process control

Audits are conducted by accredited, independent certification bodies, not by the supplier. Certification is valid for three years and includes annual surveillance audits, building a comprehensive, up-to-date compliance profile over time.

EXCiPACT certification has already been accepted in place of hundreds of direct customer audits globally. Pharmaceutical manufacturers routinely use EXCiPACT certificates and audit reports to support initial supplier qualification and to determine ongoing audit frequency for lower-risk excipients.

EXCiPACT certification is independent evidence that DC Fine Chemicals’ quality system, excipient handling, and documentation meet the GMP requirements expected by pharmaceutical manufacturers.

PharmaFine: excipients backed by independently verified GMP & EXCiPACT certifications

DC Fine Chemicals’ EXCiPACT certification directly underpins the credibility of its PharmaFine excipient portfolio, a dedicated range designed for pharmaceutical manufacturing applications.

PharmaFine excipients are handled within a quality system whose GMP alignment is no longer a claim that customers must verify themselves. It is a fact that an independent certification body has already assessed and documented.

PharmaFine is not just a product range. It is a qualified, audit-ready excipient supply, supported by a quality infrastructure that pharmaceutical manufacturers can reference with confidence in their regulatory submissions and supplier audits.

PharmaFine excipients are available in three tiers: Select, Expert, and Premium, each supported by full technical documentation, batch Certificates of Analysis, and Material Qualification Dossiers. EXCiPACT certification now adds an additional layer of independent verification to this documentation package.

What this means for DC Fine Chemicals customers

Unlike GMP requirements for active pharmaceutical ingredients, GMP compliance is not legally mandatory for excipient suppliers. Yet pharmaceutical manufacturers are increasingly expected to qualify their excipients against GMP-aligned standards, and regulators have made clear that third-party certification is an acceptable and recognised route to meeting that expectation. EXCiPACT certification remains far from universal among excipient suppliers: achieving it requires committing to an independent audit process, annual surveillance, and continuous compliance with standards that go significantly beyond what ISO 9001 alone requires.

For customers of DC Fine Chemicals, the practical benefits are direct:

  • Faster supplier qualification: certification and audit reports can be used immediately to support the qualification process, reducing the time from supplier selection to approved status
  • Reduced audit burden: through EXCiPACT certification, our excipient operations are independently audited against recognised GMP and GDP standards. This can simplify supplier qualification and reduce the need for individual customer audits. For customers requiring further verification, we also welcome on-site audits and can provide third-party audit reports
  • Lower supplier risk perception: independent verification removes ambiguity about quality system compliance
  • Stronger regulatory position: audit reports and certificates provide documented evidence for regulatory submissions and internal quality reviews
  • Reliable, consistent supply: annual surveillance audits mean compliance is monitored continuously, not only at qualification

A different kind of chemistry

DC Fine Chemicals operates manufacturing facilities in Spain and offices in the United Kingdom, supplying fine chemical raw materials to the life sciences sector. Our mission is to simplify our customers’ processes and contribute to their success by delivering high-quality materials supported by reliable service and technical expertise.

EXCiPACT certification reflects this commitment. By aligning our excipient handling with recognised GMP and GDP standards, we aim to make supplier qualification easier and more transparent for pharmaceutical manufacturers.

Through our PharmaFine excipient range, we support companies developing and manufacturing pharmaceutical products that require dependable, well-documented raw materials.

If you are qualifying excipient suppliers for GMP pharmaceutical production, our team would be happy to support your evaluation.

Contact us to discuss our PharmaFine excipient offerings, EXCiPACT, audit options, or to receive a quotation.